A review of hematopoietic stem cell transplantation for autoimmune diseases: multiple sclerosis, systemic sclerosis and Crohn's disease. Position paper of the Brazilian Society of Bone Marrow Transplantation
Hematol., Transfus. Cell Ther. (Impr.)
;
43(1): 65-86, Jan.-Mar. 2021. tab
Article
in English
| LILACS
| ID: biblio-1154293
ABSTRACT
ABSTRACT Autoimmune diseases are an important field for the development of bone marrow transplantation, or hematopoietic stem cell transplantation. In Europe alone, almost 3000 procedures have been registered so far. The Brazilian Society for Bone Marrow Transplantation (Sociedade Brasileira de Transplantes de Medula Óssea) organized consensus meetings for the Autoimmune Diseases Group, to review the available literature on hematopoietic stem cell transplantation for autoimmune diseases, aiming to gather data that support the procedure for these patients. Three autoimmune diseases for which there are evidence-based indications for hematopoietic stem cell transplantation are multiple sclerosis, systemic sclerosis and Crohn's disease. The professional stem cell transplant societies in America, Europe and Brazil (Sociedade Brasileira de Transplantes de Medula Óssea) currently consider hematopoietic stem cell transplantation as a therapeutic modality for these three autoimmune diseases. This article reviews the evidence available.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Scleroderma, Systemic
/
Crohn Disease
/
Bone Marrow Transplantation
/
Hematopoietic Stem Cell Transplantation
/
Scleroderma, Diffuse
/
Multiple Sclerosis
Limits:
Humans
Country/Region as subject:
South America
/
Brazil
Language:
English
Journal:
Hematol., Transfus. Cell Ther. (Impr.)
Journal subject:
Hematologia
/
TransfusÆo de Sangue
Year:
2021
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Associação Portuguesa de Beneficência de São José do Rio Preto/BR
/
Hospital Israelita Albert Einstein/BR
/
Universidade de São Paulo - USP/BR
Similar
MEDLINE
...
LILACS
LIS